Prevalence and predictors of prescription opioids among United States adults with long COVID

David Rhys Axon, Stephanie B. Fenwick

Open source

DOI
10.1097/md.0000000000050568
Published
2026-09-04
Container
Medicine
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/md.0000000000050568,
  title = {Prevalence and predictors of prescription opioids among United States adults with long COVID},
  author = {David Rhys Axon and Stephanie B. Fenwick},
  year = {2026},
  journal = {Medicine},
  doi = {10.1097/md.0000000000050568},
  url = {https://doi.org/10.1097/md.0000000000050568}
}

RIS

TY  - JOUR
TI  - Prevalence and predictors of prescription opioids among United States adults with long COVID
AU  - David Rhys Axon
AU  - Stephanie B. Fenwick
PY  - 2026
JO  - Medicine
DO  - 10.1097/md.0000000000050568
UR  - https://doi.org/10.1097/md.0000000000050568
ER  - 

APA

Axon, D. R., & Fenwick, S. B. (2026). Prevalence and predictors of prescription opioids among United States adults with long COVID. Medicine. https://doi.org/10.1097/md.0000000000050568

Source records